search Created with Sketch.
search Created with Sketch.

Advertisement

dermwire-tv-logo Created with Sketch.
dermwire-tv-logo Created with Sketch.

Dupixent for Adolescents priority review, Restylane Lyft via cannulas, Hyperhidrosis Awareness

November 7, 2018

FDA grants priority review for Sanofi's and Regeneron's sBLA for Dupixent (dupilumab) for adolescents. Galderma's Restylane Lyft is approved for use with a small, blunt-tip cannula for cheek augmentation and the correction of age-related midface contour deficiencies in patients over the age of 21. The Skin Cancer Foundation's 22nd annual Gala raises $600,000 to support the organization's educational campaigns, community programs, and research initiatives.November is Hyperhidrosis Awareness Month. The International Hyperhidrosis Society has information at SweatHelp.org.

Advertisement

In This Series

View More

Advertisement